Belkin Unveils New Innovative Qi2 Chargers, Powerful USB-C Solutions, Immersive Audio Products and More at IFA 2023
Belkin, a leading consumer electronics brand for 40 years, today announced 8 new products across its power, audio and connectivity categories, underscoring Belkin innovation, quality and its commitment to building products more responsibly. Belkin International can be found on the IFA show floor, Exhibit Hall 3.2, booth #119.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230831139752/en/
Belkin Unveils New Innovative Qi2 Chargers, Powerful USB-C Solutions, Immersive Audio Products and More at IFA 2023 (Photo: Business Wire)
Wireless Charging
BoostCharge Pro Universal Easy Align Wireless Charging Pad 15W
Delivers a fast and seamless charge for Qi-enabled devices at up to 15W. The large charging surface provides easy alignment, and its non-slip grip material keeps it in place if jostled or vibrates from an incoming call. It’s designed with two separate thermal protection systems to control temperatures and prevent overheating of the charger and connected devices.
BoostCharge Pro 3-in-1 Wireless Charging Pad with Qi2
Leveraging the new Qi2 standard, this 3-in-1 wireless charger1 offers perfect alignment and faster charging for Qi2-enabled devices at 15W, and Qi charging at 5W for Belkin SoundForm earbuds or other Qi-enabled devices. The USB-C port allows for dongle attachment for fast charging newer Apple Watch models. This pad is MagSafe compatible, slim and compact, allowing users to easily pack it away.
BoostCharge Convertible Qi2 Wireless Pad to Stand
The Qi2 Convertible Pad/Stand is the ultimate charging solution for fast charging at work, at home or on-the-go. The MagSafe compatible, convertible design allows users to switch between pad and stand modes, making it perfect for FaceTime, taking calls or streaming video while charging. It is versatile, reliable, compact, and easy to fold, making it the perfect fuss-free travel companion.
USB-C
BoostCharge Pro 140W 4-Port GaN Wall Charger
Charge a MacBook Pro at full speed or fast-charge an iPhone and iPad while charging two additional devices at the same time with the 140W 4-Port GaN Charger. This powerful GaN charger offers easy access to its 3x USB-C and 1x USB-A ports. It supports a wide range of USB-C devices such as smartphones, tablets, and laptops.
BoostCharge Hybrid Wall Charger 25W + Power Bank 5K
Belkin’s latest portable power solution is a power bank as well as a PD wall charger. This portable charger comes with dual charging modes, allowing users to charge directly from a wall socket or the built-in battery. This multi-functional fast charger features integrated PD3.1 PPS technology and provides high-speed safe charging to almost all PD-enabled devices.
Connectivity
Connect 5-in-1 Thunderbolt 4 Hub
The 5-in-1 Thunderbolt 4 Core Hub is portable, low-profile and fully spec’d to expand productivity across multiple devices with one Thunderbolt connection. Connect multiple monitors, safely charge devices with smart charging, transfer files faster than ever, and daisy chain up to 6 devices to increase productivity. All powered by Thunderbolt 4. Features 4 Thunderbolt 4 ports, 1 USB-A port, up to 40 Gbps data transfer speeds, dual monitor support, and Power Delivery up to 96W.
Audio
SoundForm Inspire Kids Headset
The SoundForm Inspire is creatively engineered for kids to listen safely and comfortably while learning and playing. The headset is built with 40mm drivers to deliver Belkin Signature Sound with a volume cap of 85 decibels to protect young ears. The soft, adjustable headband folds up for portability, and smaller ear cups provide an excellent fit. RockStar Mode features an additional 3.5mm output port that lets kids share audio content with a classmate or friend. A quality boom mic keeps the sound clear during distance learning, and an indicator light shows when the headset is on mute. Available in black with blue accents and grey with lavender accents.
SoundForm Adapt Headset
The ultimate tool while working from home or office, the SoundForm Adapt features clear call quality with boom microphone and environmental noise cancellation (ENC), high-quality sound and all-day comfort. Its foam ear cushion cups and adjustable headband ensure an excellent fit. Adapt is easily packable and can be folded away for travel and storage. With a long-lasting battery life of 65 hours, Adapt keeps its charge throughout the work week. Available in black.
Availability:
- BoostCharge Pro Universal Easy Align Wireless Charging Pad 15W is available to order now on belkin.com and in select retailers worldwide.
- BoostCharge Pro 3-in-1 Wireless Charging Pad with Qi2 will be available to order later this year on belkin.com and in select retailers worldwide.
- BoostCharge Convertible Qi2 Wireless Pad to Stand will be available to order beginning Q1 2024 on belkin.com and from select retailers worldwide.
- BoostCharge Pro 140W 4-Port GaN Wall Charger is available to purchase now on belkin.com and in select retailers worldwide.
- BoostCharge Hybrid Wall Charger 25W + Power Bank 5K will be available to order later this year on belkin.com and in select retailers worldwide.
- Connect 5-in-1 Thunderbolt 4 Hub is available now in select retailers worldwide.
- SoundForm Inspire Kids Headset is available to order now on belkin.com and in select retailers worldwide.
- SoundForm Adapt Headset is available to order now on belkin.com and in select retailers worldwide.
All new products are made with post-consumer recycled (PCR) plastics in line with the company’s commitment to find more responsible ways to build products. They will be on display at IFA 2023.
Media kit is available for download HERE.
About Belkin
Belkin is an accessories market leader delivering power, protection, productivity, connectivity, audio, security, and home automation solutions for a broad range of consumer electronics and enterprise environments over the last 40 years. Designed in Southern California and sold in more than 100 countries around the world, Belkin creates products that empower people to get more life out of every single day whether at home, at work or on a new adventure. In 2018 Belkin International merged with Foxconn Interconnect Technology to bolster its global influence while maintaining its steadfast focus on research and development, community, education and sustainability. Belkin remains forever inspired by people and the planet we live on.
____________________________
1 The BoostCharge Pro 3-in-1 Wireless Charging Pad with Qi2 will be sold in two versions: as a standalone pad; and with included dongle attachment for charging Apple Watch. Pricing will vary.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230831139752/en/
Contact information
Jen Wei
VP of Global Communications and Corporate Development
Comms@belkin.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Stallergenes Greer Expands Venom Immunotherapy Production Capacity With Acquisition of Entomon s.r.l.7.1.2026 12:07:00 EET | Press release
Stallergenes Greer, a global leader in allergy therapeutics, today announced that it has entered into an agreement to acquire Entomon s.r.l., an Italian company specialising in the production of certified stinging-insect venom extracts, notably of the Hymenoptera order, used for the manufacture of diagnostic preparations and Venom Immunotherapy (VIT). The transaction is expected to close by the end of January. Entomon, currently recognised as the only company in Europe capable of extracting pure venom from Hymenoptera insects, produces pharmaceutical-grade insect venom using proprietary techniques (Entomon Capillary Extracted Venom®) for medical use. Through this acquisition, Stallergenes Greer bolsters its venom manufacturing capabilities and supply of raw materials for life-saving VIT treatments, whilst safeguarding patient care continuity. Hymenoptera venom allergy is the most common trigger of severe anaphylaxis in adults1. According to the EAACI guidelines on venom immunotherapy,
ARIS Announces New CEO to Lead Agentic AI-led Strategy7.1.2026 11:00:00 EET | Press release
CEO Appointment ARIS, a global leader in process intelligence and transformation software, today announced the appointment of Guillaume Bacuvier as Chief Executive Officer. Guillaume will lead ARIS through its next phase of growth as a fully standalone company, accelerating its evolution from a market leader in Process Intelligence into a foundational platform for enterprises deploying and governing Agentic AI. Guillaume brings deep international leadership experience across technology, data, and software-enabled businesses, with a proven track record of scaling global platforms and leading complex organisations. After starting as a strategic consultant at Booz Allen Hamilton, Guillaume spent over a decade at Google, rising to Vice President in EMEA where he built and scaled some of Google’s largest data-driven businesses in Europe and held P&L responsibility across multiple countries. In the last decade, Guillaume has served as CEO of multi-continent, data-centric companies including
I Squared Capital Acquires Ramudden Global, a Leader in Traffic Management and Infrastructure Safety7.1.2026 10:00:00 EET | Press release
I Squared Capital, a leading global infrastructure investment manager, today announced that, through its flagship fund, it has agreed to acquire Ramudden Global, from funds advised by Triton Partners (“Triton”), a leading European mid-market sector-specialist investor. Ramudden Global is a leading international provider of traffic management and infrastructure safety services supporting the maintenance and upgrade of essential transport and utility networks. The company operates more than 190 depots across 13 countries in Europe and North America delivering mission-critical services that help to ensure safety, regulatory compliance and continuity of service across road, utility and broader infrastructure works. This investment underscores I Squared Capital’s commitment to investing in essential, regulated, infrastructure businesses that underpin public safety, mobility and economic activity. Ramudden operates in markets where demand is steady and growing and benefits from deep commerci
RoslinCT and BOOST Pharma Announce Strategic Manufacturing Agreement to Advance Cell Therapy for Infants with Osteogenesis Imperfecta7.1.2026 10:00:00 EET | Press release
RoslinCT, a global contract development and manufacturing organization (CDMO) specializing in advanced cell therapies, and BOOST Pharma, a clinical-stage biotechnology company developing first-in-class cell therapies for rare paediatric skeletal diseases, today announced a strategic manufacturing partnership to support the development of BOOST Pharma’s cell therapy, BT-101, for the treatment of infants with Osteogenesis Imperfecta (OI), also known as brittle bone disease. Under the service agreement, BOOST Pharma has transferred its manufacturing process to RoslinCT’s state-of-the-art facilities in Edinburgh, Scotland. The partnership will progress toward GMP manufacturing of starting materials and clinical drug product, supporting Phase III clinical development of BT-101. The therapy is an allogeneic mesenchymal stem cell (MSC) product designed to address the underlying cause of OI at the earliest stages of life. BOOST Pharma was founded on pioneering science originating from Karolins
Daiichi Sankyo and GENESIS Pharma Enter Exclusive Agreement for VANFLYTA ® Commercialization in Central and Eastern Europe7.1.2026 09:30:00 EET | Press release
Daiichi Sankyo (TSE: 4568) and GENESIS Pharma have entered into an exclusive license and supply agreement for the distribution and commercialization of VANFLYTA® (quizartinib) in 13 markets across Central and Eastern Europe for the treatment of adult patients with newly diagnosed FLT3-ITD positive acute myeloid leukemia (AML). Under the terms of the agreement, Daiichi Sankyo will be responsible for the manufacturing and supply of VANFLYTA while GENESIS Pharma will lead medical affairs, market access and commercialization efforts in Bulgaria, Croatia, Cyprus, Czech Republic, Estonia, Hungary, Latvia, Lithuania, Malta, Poland, Romania, Slovakia and Slovenia. Financial terms of the agreement are not being disclosed. VANFLYTA was approved in the EU in November 2023 for the treatment of adult patients with newly diagnosed FLT3-ITD positive AML in combination with standard cytarabine and anthracycline induction and standard cytarabine consolidation chemotherapy, and as maintenance monotherap
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom